Literature DB >> 1872020

Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.

P D Cooper1, E J Steele.   

Abstract

Crystallization of inulin with alum forms a fine (1-2 micron) suspension of electron-dense ovoids; the alum is embedded in inulin particles, which are then converted to the immune stimulant polymorphic form, gamma inulin. This very stable hybrid preparation is termed Algammulin. Preferred conditions for its preparation are described. The alum still adsorbs protein. Gamma inulin is equally able to activate the alternative pathway of complement in vitro whether free or combined as Algammulin. Gamma inulin, either free or combined as Algammulin, dissolved on heating over a narrow temperature range that can be used to characterize the polymorphic form of the inulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872020     DOI: 10.1016/0264-410x(91)90063-c

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Authors:  Nikolai Petrovsky
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

2.  The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.

Authors:  Peter D Cooper; Thomas G Barclay; Milena Ginic-Markovic; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2013-07-12       Impact factor: 4.313

3.  Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy.

Authors:  Thomas Barclay; Milena Ginic-Markovic; Martin R Johnston; Peter D Cooper; Nikolai Petrovsky
Journal:  Carbohydr Res       Date:  2012-03-10       Impact factor: 2.104

4.  Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Authors:  Peter D Cooper; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2010-12-07       Impact factor: 4.313

Review 5.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 6.  Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus.

Authors:  Arbind Kumar; Aashish Sharma; Narendra Vijay Tirpude; Yogendra Padwad; Vipin Hallan; Sanjay Kumar
Journal:  Pharmacol Rep       Date:  2022-09-20       Impact factor: 3.919

7.  Molecular characterization of a ribonucleotide reductase (nrdF) gene fragment of Mycoplasma hyopneumoniae and assessment of the recombinant product as an experimental vaccine for enzootic pneumonia.

Authors:  P K Fagan; S P Djordjevic; G J Eamens; J Chin; M J Walker
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

9.  Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.

Authors:  N E van Houten; M B Zwick; A Menendez; J K Scott
Journal:  Vaccine       Date:  2006-01-11       Impact factor: 3.641

10.  Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Authors:  P D Cooper; T G Barclay; M Ginic-Markovic; N Petrovsky
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.